CIK 0001401040 · Non-accelerated filer<br>Smaller reporting company
DiaMedica Therapeutics Inc.
Sign in to watch- Ticker
- DMAC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Canada (Federal Level)
- Entity type
- operating
- Phone
- (763) 496-5454
- Business address
- 301 CARLSON PARKWAY, SUITE 210, MINNEAPOLIS, MN, 55305
- Former names
- DiaMedica Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-01-03 | Pilnik Richard D. Director | Grant or award | +55,555 | $1.53 | $85K | 209,882 |
| 2022-12-09 | Giuffre Randall Michael Director | Purchase | +37,079 | $1.43 | $53K | 260,225 |
| 2022-12-08 | Giuffre Randall Michael Director | Purchase | +20,000 | $1.40 | $28K | 223,146 |
| 2022-12-07 | Giuffre Randall Michael Director | Purchase | +22,574 | $1.40 | $32K | 203,146 |
| 2022-12-06 | Giuffre Randall Michael Director | Purchase | +2,300 | $1.35 | $3K | 180,572 |
| 2022-12-05 | Pilnik Richard D. Director | Purchase | +35,000 | $1.39 | $48K | 154,327 |
| 2022-12-02 | Von Koch Thomas 10% owner | Sale | −2,855,847 | $1.24 | $3.5M | 0 |
| 2022-12-02 | Von Koch Thomas 10% owner | Purchase | +2,855,847 | $1.24 | $3.5M | 2,855,847 |
| 2022-12-01 | Giuffre Randall Michael Director | Purchase | +819 | $1.19 | $975 | 178,272 |
| 2022-12-01 | Giuffre Randall Michael Director | Purchase | +46,133 | $1.20 | $55K | 177,453 |
| 2022-11-30 | Giuffre Randall Michael Director | Purchase | +2,970 | $1.19 | $4K | 131,320 |
| 2022-11-29 | Giuffre Randall Michael Director | Purchase | +18,125 | $1.19 | $22K | 128,350 |
| 2022-11-16 | Pauls Dietrich John President and CEO | Purchase | +20,000 | $1.21 | $24K | 55,804 |
| 2022-09-13 | Daves Julie VanOrsdel SVP Clinical Development Oper. | Grant or award · Stock Option (right to buy) | +140,000 | 140,000 | ||
| 2022-07-08 | Von Koch Thomas 10% owner | Purchase | +207,974 | $1.33 | $276K | 2,855,827 |
| 2022-06-01 | Pauls Dietrich John President and CEO | Grant or award · Stock Option (right to buy) | +177,000 | 177,000 | ||
| 2022-06-01 | Kellen Scott CFO and Secretary | Grant or award · Stock Option (right to buy) | +60,000 | 60,000 | ||
| 2022-06-01 | Burroughs Amy L. Director | Grant or award · Stock Option (right to buy) | +13,222 | 13,222 | ||
| 2022-06-01 | Giuffre Randall Michael Director | Grant or award · Stock Option (right to buy) | +13,222 | 13,222 | ||
| 2022-06-01 | Parsons James T. Director | Grant or award · Stock Option (right to buy) | +13,222 | 13,222 |
Page 6 of 10 · 189 trades